Patents by Inventor Michael AARON

Michael AARON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-(2-(2-AMINO-6-SUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]OXAZIN-8a(8H)-YL)-THIAZOL-4-YL) AMIDES
    Publication number: 20170088556
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: September 22, 2016
    Publication date: March 30, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill
  • 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
    Patent number: 9605007
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: March 28, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
    Publication number: 20170057947
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g.
    Type: Application
    Filed: November 11, 2016
    Publication date: March 2, 2017
    Applicant: PFIZER INC.
    Inventors: MICHAEL AARON BRODNEY, JENNIFER ELIZABETH DAVOREN, AMY BETH DOUNAY, IVAN VIKTOROVICH EFREMOV, DAVID LAWRENCE FIRMAN GRAY, MICHAEL ERIC GREEN, JACLYN LOUISE HENDERSON, CHEWAH LEE, SCOT RICHARD MENTE, STEVEN VICTOR O'NEIL, BRUCE NELSEN ROGERS, LEI ZHANG
  • Mortise lock apparatus and electronic operating system
    Patent number: 9580931
    Abstract: The disclosure describes a locking system for a door with a mortise pocket. The locking system has a mortise case within the mortise pocket. The mortise case defines an alignment hole. The locking system also has a gear box with a worm gear that defines a notched passage that receives a lock knob shaft. A worm within the gear box is coupled to a motor that rotates the worm. The worm engages the worm gear such that the worm gear rotates when the worm rotates. A control board in the gear box is adapted to receive electronic signals and transmit them to the motor to cause the motor to rotate the worm. The gear box also has a worm gear hub that defines a keyed passage and a hub tab. The worm gear hub fits within the notched passage and the keyed passage receives the lock knob shaft. The worm gear also has two notches that the hub tab contacts individually when the gear hub rotates within the notched passage.
    Type: Grant
    Filed: April 25, 2012
    Date of Patent: February 28, 2017
    Assignee: Belwith Products, LLC
    Inventors: Gary L. Myers, Ashok Hirpara, Michael Aaron Cohen, John D. Veleris, Alyssa M. Nelson
  • ACTIVE SENSING SYSTEM AND METHOD OF SENSING WITH AN ACTIVE SENSOR SYSTEM
    Publication number: 20170052276
    Abstract: An active sensing system includes an agent and at least one sensor operatively associated with the agent. The at least one sensor includes one or more emitters configured and disposed to establish a sensing zone. A conflict identification module is configured and disposed to identify one or more sensor conflict regions, and an active sensor controller is operatively connected to the at least one sensor and the conflict identification module. The active sensor controller is configured and disposed to form an adjustment zone within the sensing zone to accommodate the one or more sensor conflict regions.
    Type: Application
    Filed: June 16, 2016
    Publication date: February 23, 2017
    Inventor: Michael Aaron Connor
  • EXPANDED BEAM CONNECTOR WITH DISCRETE ALIGNMENT ASSEMBLY
    Publication number: 20170052326
    Abstract: An alignment assembly for disposition in an insert for an expanded beam connector, said alignment assembly comprising: (a) at least one cylindrical sleeve having an inner first diameter, and an outer diameter configured to be received in said insert of said connector; (b) a lens disposed in said sleeve, and having a round periphery with a second diameter larger than said first diameter; and (c) a ferrule stub disposed at least partially in said sleeve, and having a round periphery with a third diameter essentially the same as the second diameter, said ferrule stub comprising a fiber stub optically coupled to said lens.
    Type: Application
    Filed: August 21, 2015
    Publication date: February 23, 2017
    Inventors: SOREN GRINDERSLEV, MICHAEL AARON KADAR-KALLEN
  • HETEROCYCLIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
    Publication number: 20170044174
    Abstract: The present invention provides, in part, compounds of Formula (I): and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), schizotypal personality disorder, cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), ADHD, Parkinson's disease, anxiety, and depression.
    Type: Application
    Filed: April 14, 2015
    Publication date: February 16, 2017
    Applicant: PFIZER INC.
    Inventors: DAVID LAWRENCE FIRMAN GRAY, LEI ZHANG, MICHAEL AARON BRODNEY, JENNIFER ELIZABETH DAVOREN, IVAN VIKTOROVICH EFREMOV, MICHAEL ERIC GREEN, STEVEN VICTOR O'NEIL, BRUCE NELSEN ROGERS
  • Spatial and temporal verification of users and/or user devices
    Patent number: 9571485
    Abstract: Approaches for facilitating spatial and temporal verification of users and/or user devices are disclosed. In some implementations, a user device may be detected within a short wireless communication range. A wireless communication session with the user device may be initiated based on the detection. Information identifying a first integrity-based certificate may be received from the user device during the wireless communication session during a first time period. Information identifying a second integrity-based certificate associated with a second time period may be provided responsive to determining that the first integrity-based certificate is a valid integrity-based certificate associated with the first time period. The second integrity-based certificate may be configured to allow network access for the user device during the second time period.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: February 14, 2017
    Assignees: Michael Aaron Le, GXM Consulting LLC
    Inventors: Michael Aaron Le, James Yeager
  • 1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS
    Publication number: 20170029390
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, traumatic brain injury, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.
    Type: Application
    Filed: July 28, 2016
    Publication date: February 2, 2017
    Applicant: PFIZER INC.
    Inventors: CHRISTOPHER RYAN BUTLER, LAURA ANN MCALLISTER, ELIZABETH MARY BECK, MICHAEL AARON BRODNEY, ADAM MATTHEW GILBERT, CHRISTOPHER JOHN HELAL, DOUGLAS SCOTT JOHNSON, JUSTIN IAN MONTGOMERY, STEVEN VICTOR O'NEIL, BRUCE NELSEN ROGERS, PATRICK ROBERT VERHOEST, DAMIEN WEBB
  • CONTRACEPTIVE AND RELATED DEVICE
    Publication number: 20170020718
    Abstract: An intravaginal ring for the controlled release of at least one bioactive agent may further contain at least one of a non-bioabsorbable microparticulate ion-exchanging polymer, a fully bioabsorbable polymeric matrix, a biostable hydrophilic elastomeric polymeric matrix, a biostable amphiphilic elastomeric polymeric matrix, a biostable elastomeric polymeric matrix containing an inorganic microparticulate, and a biostable elastomeric porous polymeric matrix, each to aid in the release and/or modulate the release of the bioactive agent.
    Type: Application
    Filed: April 1, 2015
    Publication date: January 26, 2017
    Applicant: POLY-MED, INC.
    Inventors: Kenneth David Gray, Jr., Michael Aaron Vaughn, Georgios Theofanis Hilas
  • Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
    Patent number: 9550795
    Abstract: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: January 24, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Christopher John Helal, Brian Thomas O'Neill
  • 2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,3-Thiazol-4-yl Amides
    Publication number: 20170008911
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: July 20, 2016
    Publication date: January 12, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Substituted 1,7-naphthyridines as dopamine D1 ligands
    Patent number: 9540352
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), schizotypal personality disorder, cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), ADHD, Parkinson's disease, anxiety, and depression.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: January 10, 2017
    Assignee: Pfizer Inc.
    Inventors: David Lawrence Firman Gray, Lei Zhang, Michael Aaron Brodney, Michael Eric Green, Chakrapani Subramanyam
  • Heteroaromatic compounds and their use as dopamine D1 ligands
    Patent number: 9527831
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), age-related cognitive decline, dementia, and Parkinson's disease.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: December 27, 2016
    Assignee: PFIZER INC.
    Inventors: Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green, Jaclyn Louise Henderson, Chewah Lee, Scot Richard Mente, Steven Victor O'Neil, Bruce Nelsen Rogers, Lei Zhang
  • Portable device for attaching a connector to an optical fiber
    Patent number: 9481129
    Abstract: A portable device for attaching a connector to an optical fiber, the optical fiber having an end, the device comprising means for receiving the optical fiber at the end of the optical fiber; and a connector station for autonomously attaching the connector to the optical fiber.
    Type: Grant
    Filed: February 7, 2012
    Date of Patent: November 1, 2016
    Assignees: COMMSCOPE CONNECTIVITY BELGIUM BVBA
    Inventors: Danny Willy August Verheyden, David Donald Erdman, Michael Gurreri, Randall Bobby Paul, Jan Watté, Robert Charles Flaig, Alan Edward Plotts, Michael Aaron Kadar-Kallen, Shelly Anne Buchter, Jan Vandenbroeck, Patrick Billet, Stefano Beri, André Johannes Maria Hilderink, Hernes Jacobs, Petrus Theodorus Rutgers, Petrus Theodorus Krechting, Martijn Johannes Wolbers, Walter Mattheus, Cristian-Radu Radulescu, Paul Vits, Karel Johannes Van Assenbergh, Pieter Cornelis Johan De Jager, Henk Jan Theodoor Van Der Pol
  • VIBRATION GENERATOR FOR GENERATING MECHANICAL VIBRATIONS
    Publication number: 20160270891
    Abstract: Vibration generator for generating mechanical vibrations for a dental handpiece, comprising a rotation driving means, a vibration generating element rotationally coupled to the rotation driving means and comprising an imbalanced vibrating portion and a vibrating element in mechanical communication with the vibration generating element, wherein the rotation of the vibration generating element causes the imbalanced vibrating portion to generate vibrations of the vibrating element and the vibrating element is configured to deliver the vibrations to an object.
    Type: Application
    Filed: March 20, 2015
    Publication date: September 22, 2016
    Inventor: Michael Aaron Fisher
  • DISPENSING MATERIAL FROM A DENTAL HANDPIECE
    Publication number: 20160270876
    Abstract: Devices and methods for dispensing material from a dental handpiece. In one example, the method includes receiving an input that indicates that an amount of the material is to be dispensed from the container of the dental handpiece. The method also includes rotating an electric motor to rotate an imbalanced mass to vibrate a vibration transmission element that vibrates the material in the container. The method also includes dispensing the amount of the material from the container with a piston based on the input.
    Type: Application
    Filed: March 18, 2016
    Publication date: September 22, 2016
    Inventors: Michael Aaron Fisher, Robert Thomas St. Louis, Gopikrishnan Soundararajan, Matteo Riccardo Bosisio, Michael Carl Dunaway
  • 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
    Patent number: 9428523
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: August 30, 2016
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Modularized interposer
    Patent number: 9417408
    Abstract: An interposer for optically coupling an optical device (OD) to a fiber, the OD mounted on a substrate, the interposer comprising: (a) a lens component comprising at least one lens for optically coupling with the OD the lens having a first optical axis, a first surface for mating with the substrate, and a second surface for mating with a third surface of a fiber component; (b) the fiber component comprising the third surface and a cavity for receiving at least one fiber and holding the fiber along a second optical axis, the first and second optical axes being perpendicular; and (c) wherein at least one of the lens component or the fiber component comprises a reflective surface for optically coupling the lens to a point along the second optical axis and adjacent the cavity.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: August 16, 2016
    Assignee: Tyco Electronics Corporation
    Inventor: Michael Aaron Kadar-Kallen
  • Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
    Patent number: 9403846
    Abstract: The present invention provides compounds of formula I, wherein the variables R1, R2, R5 and b are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: August 2, 2016
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Brian Thomas O'Neill, Christopher Ryan Butler, Erik Alphie LaChapelle